Sqilline Health, a leading innovator in AI-driven clinical data structuring, is proud to announce the appointment of Cyril Schiever, President Mid-Europe at MSD, to its Board of Directors.
With over 30 years of global leadership in the pharmaceutical and healthcare sectors, Cyril brings deep expertise in oncology, data-driven innovation, and strategic market development. He is widely recognized for his ability to navigate complex healthcare landscapes and drive meaningful transformation, particularly in oncology.
Cyril is a passionate advocate for innovation, equitable healthcare access, and leadership development. Beyond his professional role, he actively champions initiatives that promote sustainability and the adoption of emerging health technologies.
Cyril’s appointment comes as Sqilline Health enters a new phase of international expansion into Europe’s largest markets, advancing the company’s mission to deliver Clarity for Cancer Care by transforming oncology data into evidence.
About Sqilline Health
Sqilline Health is a leading healthtech company specializing in AI-powered clinical data structuring and real-world evidence generation in Oncology. Through its Danny Platform, Sqilline enables healthcare providers and researchers to leverage real-world data to improve patient outcomes, accelerate research, and support evidence-based care.
Media Contact
Nadia Mesika | Sqilline Health | +359 885 030 868 | nadia.mesika@sqilline.com | www.sqilline.com
